Cited by 3,114T-cell and B-cell ImmunologyCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.

Molecular mechanisms of T cell co-stimulation and co-inhibition

Open access

Chen, Lieping, Flies, Dallas B.·2013·Nature Reviews Immunology

Open this paper in CoChat — free account

Abstract

Co-stimulatory and co-inhibitory receptors have a pivotal role in T cell biology, as they determine the functional outcome of T cell receptor (TCR) signalling. The classic definition of T cell co-stimulation continues to evolve through the identification of new co-stimulatory and co-inhibitory receptors, the biochemical characterization of their downstream signalling events and the delineation of their immunological functions. Notably, it has been recently appreciated that co-stimulatory and co-inhibitory receptors display great diversity in expression, structure and function, and that their functions are largely context dependent. Here, we focus on some of these emerging concepts and review the mechanisms through which T cell activation, differentiation and function is controlled by co-stimulatory and co-inhibitory receptors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nri3405

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Self-citation
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
T cell exhaustion
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
The B7 family revisited
Greenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., & Sharpe, A. H. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090847 · Cited by 2,072
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4
Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., et al. (2011) · Science · doi:10.1126/science.1202947 · Cited by 1,860

Flagged first, then by citations

Show all 135 references

Research works printed but not linked: 1

Lafferty, K. J. & Cunningham, A. J. A. New analysis of allogeneic interactions. J. Immunol. 112, 436–437 (1975). Lafferty and Cunningham extended the Bretscher and Cohn two-signal model to suggest that T cells require two signals for activation.

Sorted by citations

Items 801–900 of 1,003

Costimulation molecules differentially regulate the ERK-Zfp831 axis to shape T follicular helper cell differentiation
Wan, S., Ni, L., Zhao, X., Liu, X., Xu, W., Jin, W., Wang, X., & Dong, C. (2021) · Immunity · doi:10.1016/j.immuni.2021.09.018 · Cited by 45
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
Dhawan, M. K., Rabaan, A. A., Fawarah, M. M., Almuthree, S. A., Alsubki, R. A., Alfaraj, A. H., Mashraqi, M. M., Alshamrani, S., Abduljabbar, W. A., Alwashmi, A. S. S., et al. (2023) · Vaccines · doi:10.3390/vaccines11010101 · Cited by 45
Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies
Keshavarz, A., Salehi, A., Khosravi, S., Shariati, Y., Nasrabadi, N., Kahrizi, M. S., Maghsoodi, S., Mardi, A., Azizi, R., Jamali, S., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03163-w · Cited by 47
“2 (CD86)] expressed on the antigen-presenting cells with the co-receptor protein CD28 expressed on the T-cells provides signal 2 [19].”
Background
Pharmacological Effects and Clinical Prospects of Cepharanthine
Liang, D., Li, Q., Du, L., & Dou, G. (2022) · Molecules · doi:10.3390/molecules27248933 · Cited by 44
Complex Analysis of Single-Cell RNA Sequencing Data
Khozyainova, A. A., Valyaeva, A. A., Arbatsky, M. S., Isaev, S. V., Iamshchikov, P. S., Volchkov, E., Sabirov, M. S., Zainullina, V. R., Chechekhin, V. I., Vorobev, R. S., et al. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923020074 · Cited by 47
“In particular, this tool combines the gene expression profiles of single cells with the widely available information on the ligand–receptor interactions [144, 145] in order to create an affinity matrix that is transferred into a three-dimensional space.”
Method
BTNL8, a butyrophilin-like molecule that costimulates the primary immune response
Chapoval, A. I., Smithson, G. M., Brunick, L., Mesri, M., Boldog, F. L., Andrew, D. P., Khramtsov, N. V., Feshchenko, E. A., Starling, G. C., & Mézeš, P. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.08.003 · Cited by 45
Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer
Zamarin, D., & Wolchok, J. D. (2014) · Molecular Therapy — Oncolytics · doi:10.1038/mto.2014.4 · Cited by 44
Attenuation of lymphocyte immune responses during Mycobacterium avium complex-induced lung disease due to increasing expression of programmed death-1 on lymphocytes
Shu, C., Wang, J., Wu, M., Wu, C., Lai, H., Lee, L., Chiang, B., & Yu, C. (2017) · Scientific Reports · doi:10.1038/srep42004 · Cited by 44
Metabolism-associated danger signal-induced immune response and reverse immune checkpoint-activated CD40+ monocyte differentiation
Dai, J., Fang, P., Saredy, J., Xi, H., Cueto, R., Yang, W. Y., Choi, E. T., Ji, Y. H., Mao, W., Yang, X., et al. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0504-1 · Cited by 46
Immune Checkpoints as the Immune System Regulators and Potential Biomarkers in HIV-1 Infection
Sperk, M., van Domselaar, R., & Neogi, U. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072000 · Cited by 44
Co-signaling receptors regulate T-cell plasticity and immune tolerance
Shen, H. (2018) · Frontiers in bioscience · doi:10.2741/4710 · Cited by 44
Advances in siRNA delivery strategies for the treatment of MDR cancer
Subhan, M. A., Attia, S. A., & Torchilin, V. P. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119337 · Cited by 46
Biomarkers in Immunotherapy-Based Precision Treatments of Digestive System Tumors
Zeng, Z., Yang, B., & Liao, Z. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.650481 · Cited by 44
Nitric oxide favours tumour-promoting inflammation through mitochondria-dependent and -independent actions on macrophages
Drehmer, D., Luiz, J. P. M., Speck‐Hernandez, C. A., Alves-Filho, J. C., Hussell, T., Townsend, P. A., & Moncada, S. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102350 · Cited by 48
“CD86 binding to CD28 on the T cell [40], promoting their activation and expansion.”
Background
Cardiovascular Toxicity With PD-1/PD-L1 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis
Liu, S., Gao, W., Ning, Y., Zou, X., Zhang, W., Zeng, L., & Liu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.908173 · Cited by 46
“The second signal is also called the costimulatory signal, which provides positive and negative signals modulating T cell function (2, 3).”
Background
Ozone Pollution, Oxidative Stress, Regulatory T Cells and Antioxidants
Rivas-Arancibia, S., Hernández-Orozco, E., Rodrı́guez-Martı́nez, E., Valdés‐Fuentes, M., Cornejo-Trejo, V., Pérez-Pacheco, N., Dorado-Martı́nez, C., Zequeida-Carmona, D., & Caleti, I. E. (2022) · Antioxidants · doi:10.3390/antiox11081553 · Cited by 45
“Antioxidants 2022, 11, x FOR PEER REVIEW 9 of 23 antitumor response because it promotes the release of adenosi , which has an inh bitory effect on the activity of Teff lymphocytes nd APCs through the adenosine A2A receptor (A2AR) pathway [52,53].”
BackgroundInfluential
The Role of the CD28 Family Receptors in T-Cell Immunomodulation
Ciesielska-Figlon, K., & Lisowska, K. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021274 · Cited by 48
“The immune synapse is the control site for the transmitted signal from the TCR complex [23].”
Background
T cell-based cancer immunotherapy: opportunities and challenges
Ma, K., Xu, Y., Cheng, H., Tang, K., Ma, J., & Huang, B. (2025) · 中国科学通报：英文版 · doi:10.1016/j.scib.2025.03.054 · Cited by 47
Proximity between LAG-3 and the T cell receptor guides suppression of T cell activation and autoimmunity
Du, J., Chen, H., You, J., Hu, W., Liu, J., Qiao, L., Zhang, Y., Gao, J., Lin, M., Foster, C., et al. (2025) · Cell · doi:10.1016/j.cell.2025.06.004 · Cited by 50
Smoking activates cytotoxic CD8+ T cells and causes survivin release in rheumatoid arthritis
Wasén, C., Turkkila, M., Bossios, A., Erlandsson, M. C., Andersson, K., Ekerljung, L., Malmhäll, C., Brisslert, M., Silfverswärd, S. T., Lundbäck, B., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.12.009 · Cited by 43
CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8+ T Cell–Relevant Genes
Aznar, M. A., Labiano, S., Díaz‐Lagares, Á., Molina, C., Garasa, S., Azpilikueta, A., Etxeberría, I., Sánchez-Paulete, A. R., Korman, A. J., Esteller, M., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0159 · Cited by 44
Cross-talk between T Cells and Hematopoietic Stem Cells during Adoptive Cellular Therapy for Malignant Glioma
Wildes, T. J., Grippin, A., Dyson, K. A., Wummer, B. M., Damiani, D. J., Abraham, R. S., Flores, C. T., & Mitchell, D. A. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3061 · Cited by 42
Exploring major signaling cascades in melanomagenesis: a rationale route for targetted skin cancer therapy
Dantonio, P. M., Klein, M., Freire, M. R. V. B., Araujo, C. D. N., Chiacetti, A. C., & Correa, R. G. (2018) · Bioscience Reports · doi:10.1042/bsr20180511 · Cited by 47
MUC1 Mucin: A Putative Regulatory (Checkpoint) Molecule of T Cells
Agrawal, B., Gupta, N., & Konowalchuk, J. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02391 · Cited by 44
Toxoplasma: Immunity and Pathogenesis
Khan, I. A., Ouellette, C., Chen, K., & Moretto, M. M. (2019) · Current Clinical Microbiology Reports · doi:10.1007/s40588-019-0114-5 · Cited by 43
Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus
Zhou, H., Li, B., Li, J., Wu, T., Jin, X., Yuan, R. R., Shi, P., Zhou, Y., Li, L., & Yu, F. H. Z. (2019) · Mediators of Inflammation · doi:10.1155/2019/8450947 · Cited by 43
Regulation of peripheral and central immunity: Understanding the role of Src homology 2 domain-containing tyrosine phosphatases, SHP-1 & SHP-2
Garg, M., Wahid, M., & Khan, F. (2019) · Immunobiology · doi:10.1016/j.imbio.2019.09.006 · Cited by 43
Fighting Persistence: How Chronic Infections with Mycobacterium tuberculosis Evade T Cell-Mediated Clearance and New Strategies To Defeat Them
Ankley, L. M., Thomas, S. M., & Olive, A. J. (2020) · Infection and Immunity · doi:10.1128/iai.00916-19 · Cited by 44
Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypes
Klaver, Y., Rijnders, M., Oostvogels, A. A. M., Wijers, R., Smid, M., Grünhagen, D. J., Verhoef, C. K., Sleijfer, S., Lamers, C., & Debets, R. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000271 · Cited by 43
A biomimetic five-module chimeric antigen receptor ( 5M CAR) designed to target and eliminate antigen-specific T cells
Kobayashi, S., Thelin, M. A., Parrish, H. L., Deshpande, N. R., Lee, M. S., Karimzadeh, A., Niewczas, M. A., Serwold, T. F., & Kuhns, M. S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012495117 · Cited by 42
Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1
Renrick, A. N., Thounaojam, M. C., de Aquino, M. T. P., Chaudhuri, E., Pandhare, J., Dash, C., & Shanker, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.607044 · Cited by 43
ApoB-Specific CD4+ T Cells in Mouse and Human Atherosclerosis
Marchini, T., Hansen, S., & Wolf, D. (2021) · Cells · doi:10.3390/cells10020446 · Cited by 48
Immune response in bacterial and Candida sepsis
Patricio, P., Paiva, J. A., & Borrego, L. M. (2019) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2019.00011 · Cited by 42
TNF/TNFR Superfamily Members in Costimulation of T Cell Responses—Revisited
Watts, T. H., Yeung, K. K. M., Yu, T., Lee, S., & Eshraghisamani, R. (2025) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082423-040557 · Cited by 46
Stereo-cell: Spatial enhanced-resolution single-cell sequencing with high-density DNA nanoball-patterned arrays
Liao, S., Zhou, X., Liu, C., Liu, C., Hao, S., Luo, H., Hou, H., Liu, Q., Zhang, Z., Xiao, L., et al. (2025) · Science · doi:10.1126/science.adr0475 · Cited by 43
Self-citation
The Role of Immune Checkpoint Inhibitors in Cancer Therapy: Mechanism and Therapeutic Advances
Chen, H., Yang, H., Guo, L., & Sun, Q. (2025) · MedComm · doi:10.1002/mco2.70412 · Cited by 47
“This interaction drives T cell proliferation, IL-2 secretion, and expression of survival genes, such as Bcl-2 family members, via PI3K/AKT and nuclear factor-kappaB (NF-κ B) pathway activation, enabling clonal expansion and effector differentiation [25].”
Safety ofBifidobacterium animalissubsp.lactis(B. lactis) strain BB-12-supplemented yogurt in healthy adults on antibiotics: a phase I safety study
Merenstein, D. J., Tan, T., Molokin, A., Smith, K. H., Roberts, R., Shara, N. M., Mete, M., Sanders, M. E., & Solano-Aguilar, G. I. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1005484 · Cited by 42
Flt3 Ligand Treatment Attenuates T Cell Dysfunction and Improves Survival in a Murine Model of Burn Wound Sepsis
Patil, N. K., Bohannon, J. K., Luan, L., Guo, Y., Fensterheim, B. A., Hernandez, A., Wang, J., & Sherwood, E. R. (2016) · Shock · doi:10.1097/shk.0000000000000688 · Cited by 44
Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppression
Chen, L., Yi, X., Goswami, S., Ahn, Y., Roybal, J. D., Yang, Y., Diao, L., Peng, D., Peng, D. H., Fradette, J. J., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1234570 · Cited by 42
Self-citation
Dendritic Cell Dysfunction in Patients with End-stage Renal Disease
Kim, J. U., Kim, M., Kim, S., Nguyen, T. T., Kim, E.-H., Lee, S., Kim, S., & Kim, H. (2017) · Immune Network · doi:10.4110/in.2017.17.3.152 · Cited by 42
A novel role for coinhibitory receptors/checkpoint proteins in the immunopathology of sepsis
Fallon, E. A., Girard, B., Chung, C., Lomas‐Neira, J., Heffernan, D. S., Monaghan, S. F., & Ayala, A. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mir0917-377r · Cited by 45
Chimeric Antigen Receptor T Cell Therapy for Solid Tumors: Current Status, Obstacles and Future Strategies
Heyman, B. M., & Yang, Y. (2019) · Cancers · doi:10.3390/cancers11020191 · Cited by 43
Self-Assembled Multivalent Aptamer Nanoparticles with Potential CAR-like Characteristics Could Activate T Cells and Inhibit Melanoma Growth
Bai, C., Gao, S., Hu, S., Liu, X., Li, H., Dong, J., Huang, A., Zhu, L., Zhou, P., Li, S., et al. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.03.002 · Cited by 42
Kaempferol and Its Glycoside, Kaempferol 7-O-rhamnoside, Inhibit PD-1/PD-L1 Interaction In Vitro
Kim, J. H., Kim, Y. S., Choi, J., Li, W., Lee, E. J., Park, J.-W., Song, J., & Chung, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093239 · Cited by 42
A metabolic switch to memory CAR T cells: Implications for cancer treatment
Rostamian, H., Fallah-Mehrjardi, K., Khakpoor-Koosheh, M., Pawelek, J. M., Hadjati, J., Brown, C. E., & Mirzaei, H. R. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.12.004 · Cited by 44
Immune Checkpoint-Related Gene Polymorphisms Are Associated With Primary Immune Thrombocytopenia
Wang, S., Zhang, X., Leng, S., Xu, Q., Sheng, Z., Zhang, Y., Yu, J., Feng, Q., Hou, M., Peng, J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.615941 · Cited by 42
PD-1 signaling pathway in sepsis: Does it have a future?
Chen, R., & Zhou, L. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108742 · Cited by 42
Co-Stimulatory Bispecific Antibodies Induce Enhanced T Cell Activation and Tumor Cell Killing in Breast Cancer Models
Warwas, K. M., Meyer, M., Gonçalves, M., Moldenhauer, G., Bulbuc, N., Knabe, S., Luckner‐Minden, C., Ziegelmeier, C., Heußel, C. P., Zörnig, I., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.719116 · Cited by 47
Immune Cycle‐Based Strategies for Cancer Immunotherapy
Li, Y., Liu, X., Zhang, X., Pan, W., Li, N., & Tang, B. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202107540 · Cited by 42
Cluster of differentiation antigens: essential roles in the identification of teleost fish T lymphocytes
Tian, H., Xing, J., Tang, X., Chi, H., Sheng, X., & Zhan, W. (2022) · Marine Life Science & Technology · doi:10.1007/s42995-022-00136-z · Cited by 46
“There are several other pivotal surface-associated molecules involved in the activation, proliferation and differentiation of T cells, such as CD28, cytotoxic T lymphocyte antigen 4 (CTLA-4/CD152), CD40L (CD154) and CD2.”
BackgroundInfluential
Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints
Franzese, O., & Graziani, G. (2022) · Cancers · doi:10.3390/cancers14225633 · Cited by 44
Advances in promoting chimeric antigen receptor T cell trafficking and infiltration of solid tumors
Hong, M., Talluri, S., & Chen, Y. Y. (2023) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2023.103020 · Cited by 42
Multivalent Nanomaterials: Learning from Vaccines and Progressing to Antigen-Specific Immunotherapies
Hartwell, B. L., Antúnez, L. R., Sullivan, B. P., Thati, S., Sestak, J. O., & Berkland, C. J. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24273 · Cited by 41
Programmed death-ligand-1 expression in advanced gastric cancer detected with RNA in situ hybridization and its clinical significance
Yuan, J., Zhang, J., Zhu, Y., Li, N., Tian, T., Li, Y., Li, Y., Li, Z., Lai, Y., Gao, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9381 · Cited by 41
Immunothérapie des cancers : rationnel et avancées récentes
Granier, C., Karaki, S., Roussel, H., Badoual, C., Tran, T., Anson, M., Fabre, E., Oudard, S. M., & Tartour, É. (2016) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2016.05.023 · Cited by 46
Contemporary treatment of metastatic renal cell carcinoma
Stukalin, I., Alimohamed, N. S., & Heng, D. Y. C. (2016) · Oncology Reviews · doi:10.4081/oncol.2016.295 · Cited by 41
Costimulation Blockade in Kidney Transplantation
Malvezzi, P., Jouvé, T., & Rostaing, L. P. E. (2016) · Transplantation · doi:10.1097/tp.0000000000001344 · Cited by 41
Emerging infection and sepsis biomarkers: will they change current therapies?
Jacobs, L., & Wong, H. R. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1222272 · Cited by 45
Chimeric PD-1:28 Receptor Upgrades Low-Avidity T cells and Restores Effector Function of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy
Schlenker, R., Olguín-Contreras, L. F., Leisegang, M., Schnappinger, J., Disovic, A., Rühland, S., Nelson, P. J., Leonhardt, H., Harz, H., Wilde, S., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1922 · Cited by 41
Toll like Receptor 2 engagement on CD4+ T cells promotes TH9 differentiation and function
Karim, A. F., Reba, S. M., Li, Q., Boom, W. H., & Rojas, R. E. (2017) · European Journal of Immunology · doi:10.1002/eji.201646846 · Cited by 41
Aminoisoxazoles as Potent Inhibitors of Tryptophan 2,3-Dioxygenase 2 (TDO2)
Pei, Z., Mendonca, R. V., Gazzard, L. J., Pastor, R. M., Goon, L. H., Gustafson, A. E., VanderPorten, E. C., Hatzivassiliou, G., DeMent, K., Cass, R. T., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00427 · Cited by 43
Antitumor Immunity Is Controlled by Tetraspanin Proteins
Schaper, F., & van Spriel, A. B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01185 · Cited by 41
Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies
Sasso, E., D’Avino, C., Passariello, M., D’Alise, A. M., Siciliano, D., Esposito, M. L., Froechlich, G., Cortese, R., Scarselli, E., Zambrano, N., et al. (2018) · mAbs · doi:10.1080/19420862.2018.1496772 · Cited by 41
Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma
Labriola, M., Batich, K. A., Zhu, J., McNamara, M. A., Harrison, M. R., Armstrong, A. J., George, D. J., & Zhang, T. (2019) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2019.01.017 · Cited by 41
Interaction of CD99 and its ligand upregulates IL-6 and TNF-α upon T cell activation
Takheaw, N., Earwong, P., Laopajon, W., Pata, S., & Kasinrerk, W. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217393 · Cited by 41
Role of the PD‐1/PD‐L1 Signaling in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Recent Insights and Future Directions
Mi, Y., Han, J., Zhu, J., & Jin, T. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02495-7 · Cited by 43
Modulation of dendritic cell and T cell cross-talk during aging: The potential role of checkpoint inhibitory molecules
Gardner, J. K., Mamotte, C. D. S., Jackaman, C., & Nelson, D. J. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.07.002 · Cited by 40
Regulatory T Cells and Cancer: A Two-Sided Story
Wang, K., & Vella, A. T. (2016) · Immunological Investigations · doi:10.1080/08820139.2016.1197242 · Cited by 43
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Liu, Z., Xu, X., Liu, H., Zhao, X., Yang, C., & Fu, R. (2023) · Experimental Hematology & Oncology · doi:10.1186/s40164-023-00456-5 · Cited by 40
“[34, 35], which can be expressed on the surface of a variety of cells [36–38].”
Background
Extracellular vesicle‐packaged lncRNA from cancer‐associated fibroblasts promotes immune evasion by downregulating HLA‐A in pancreatic cancer
Yao, H., Huang, C., Zou, J., Liang, W., Zhao, Y., Yang, K., Zhong, Z., Zhou, S., Li, J., Li, Y., et al. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12484 · Cited by 43
“Major histocompatibility complex class I (MHC-I), also named human leukocyte antigen (HLA) in humans, is a set of surface proteins that play an essential role in immune recognition by CD8 + T cells (Chen & Flies, 2013).”
Background
Post-translational modifications of cancer immune checkpoints: mechanisms and therapeutic strategies
Jia, H., Jiang, L., Shen, X., Ye, H., Li, X., Zhang, L., Hu, Y., Song, D., Jia, H., & Wang, Z. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02397-5 · Cited by 49
“2) expressed by DCs [15, 16].”
Bone Marrow Mesenchymal Stromal Cells Induce Proliferative, Cytokinic and Molecular Changes During the T Cell Response: The Importance of the IL-10/CD210 Axis
Najar, M., Raicevic, G., Fayyad‐Kazan, H., Bruyn, C. D., Bron, D., Toungouz, M., & Lagneaux, L. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9567-3 · Cited by 40
The importance of co‐stimulation in the orchestration of T helper cell differentiation
Coquet, J. M., Rausch, L., & Borst, J. G. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.45 · Cited by 43
Dichotomous Expression of TNF Superfamily Ligands on Antigen-Presenting Cells Controls Post-priming Anti-viral CD4+ T Cell Immunity
Chang, Y.-H., Wang, K. C., Chu, K.-L., Clouthier, D., Tran, A., Perez, M. S. T., Zhou, A. C., Sater, A. A. A., & Watts, T. H. (2017) · Immunity · doi:10.1016/j.immuni.2017.10.014 · Cited by 40
Structure–Function Analysis of Immune Checkpoint Receptors to Guide Emerging Anticancer Immunotherapy
Acúrcio, R. C., Scomparin, A., Conniot, J., Salvador, J. A. R., Satchi‐Fainaro, R., Florindo, H. F., & Guedes, R. C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00541 · Cited by 40
CCR7 Is Recruited to the Immunological Synapse, Acts as Co-stimulatory Molecule and Drives LFA-1 Clustering for Efficient T Cell Adhesion Through ZAP70
Laufer, J. M., Kindinger, I., Artinger, M., Pauli, A., & Legler, D. F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03115 · Cited by 41
Abatacept in the treatment of localized scleroderma: A pediatric case series and systematic literature review
Kalampokis, I., Yi, B. Y., & Smidt, A. C. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.03.020 · Cited by 40
Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer
Hu, Y. Y., Paris, S., Bertolet, G., Barsoumian, H. B., He, K., Sezen, D., Chen, D., Wasley, M. D., SILVA, J. D., Mitchell, J., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01621-4 · Cited by 40
“LAG3 and TIGIT can deliver inhibitory signals that regulate immune cell homeostasis, T cell activation, and proliferation [24].”
Background
The Interplay between T Cells and Cancer: The Basis of Immunotherapy
Chen, C., Liu, X., Chang, C., Wang, H. Y., & Wang, R. (2023) · Genes · doi:10.3390/genes14051008 · Cited by 42
Particle-Based Artificial Antigen-Presenting Cell Systems for T Cell Activation in Adoptive T Cell Therapy
Hou, F., Guo, Z., Ho, M. T., Hui, Y., & Zhao, C. (2024) · ACS Nano · doi:10.1021/acsnano.3c10180 · Cited by 40
The viral etiology of EBV-associated gastric cancers contributes to their unique pathology, clinical outcomes, treatment responses and immune landscape
Salnikov, M. Y., MacNeil, K. M., & Mymryk, J. S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1358511 · Cited by 43
“In conjunction with the ligation of co-stimulatory molecules between the APC and T cell, this two step process triggers proliferation and survival of antigen speci ﬁ c T cells (193).”
Background
Proximity-dependent labeling identifies dendritic cells that drive the tumor-specific CD4 + T cell response
Chudnovskiy, A., Castro, T. B. R., Nakandakari-Higa, S., Cui, A., Lin, C., Sade-Feldman, M., Phillips, B. K., Pae, J., Mesin, L., Bortolatto, J., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adq8843 · Cited by 41
“…H2-DMa ) ( 36 , 63 , 64 ) and DC maturation ( Traf1 and Stat1 ) ( 65 , 66 ), costimulatory molecules ( Cd40 , Cd1d1 , Cd70 , Cd200 , and Cd48 ) ( 67 ), and chemokines and cytokines important for T cell–mediated antitumor immunity ( Cxcl9 , Cxcl16 , and Ebi3 ) ( 17 , 58 , 68 , 69 ) (data file…”
Advancements in clinical research and emerging therapies for triple-negative breast cancer treatment
Xu, L., Xu, P., Wang, J., Ji, H., Zhang, L., & Tang, Z. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177202 · Cited by 42
NKT cell-targeted vaccination plus anti-4–1BB antibody generates persistent CD8 T cell immunity against B cell lymphoma
Kobayashi, T., Doff, B. L., Rearden, R. C., Leggatt, G. R., & Mattarollo, S. R. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.990793 · Cited by 39
T Helper Cell Activation and Expansion Is Sensitive to Glutaminase Inhibition under Both Hypoxic and Normoxic Conditions
Sener, Z., Cederkvist, F. H., Volchenkov, R., Holen, H. L., & Skålhegg, B. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160291 · Cited by 39
Glutamine Administration in Early or Late Septic Phase Downregulates Lymphocyte PD‐1/PD‐L1 Expression and the Inflammatory Response in Mice With Polymicrobial Sepsis
Hu, Y., Hsiung, Y., Pai, M., & Yeh, S. (2017) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607117695245 · Cited by 41
The Immunology of Melanoma
Ko, J. S. (2017) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2017.06.001 · Cited by 39
RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells
Vallois, D., Dupuy, A., Lemonnier, F., Allen, G., Missiaglia, E., Fataccioli, V., Ortonne, N., Clavert, A., Delarue, R., Rousselet, M., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.186767 · Cited by 39
Advances in the systemic treatment of melanoma brain metastases
Oliva, I. C. G., Schvartsman, G., & Tawbi, H. A. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy185 · Cited by 40
Engineered Adoptive T-cell Therapy Prolongs Survival in a Preclinical Model of Advanced-Stage Ovarian Cancer
Anderson, K. G., Voillet, V., Bates, B. M., Chiu, E. Y., Burnett, M. G., Garcia, N. M., Oda, S. K., Morse, C. B., Stromnes, I. M., Drescher, C. W., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0258 · Cited by 40
Comprehensive landscape of immune-checkpoints uncovered in clear cell renal cell carcinoma reveals new and emerging therapeutic targets
Roux, D. T., Sautreuil, M., Bentriou, M., Verine, J., Palma, M. B., Daouya, M., Bouhidel, F. A., Lemler, S., LeMaoult, J., Desgrandchamps, F., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02530-x · Cited by 42
The Anticancer Potential of T Cell Receptor-Engineered T Cells
Ecsedi, M., McAfee, M. S., & Chapuis, A. G. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.09.002 · Cited by 42
Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches
Noh, J., Seo, H., Lee, J., & Jung, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218000 · Cited by 40
Emerging treatment options for patients with high-risk myelodysplastic syndrome
Bewersdorf, J. P., Carraway, H. E., & Prébet, T. (2020) · Therapeutic Advances in Hematology · doi:10.1177/2040620720955006 · Cited by 39
TLR2 engagement on CD4+ T cells enhances effector functions and protective responses to Mycobacterium tuberculosis
Reba, S. M., Li, Q., Onwuzulike, S., Ding, X., Karim, A. F., Hernandez, Y., Fulton, S. A., Harding, C. V., Lancioni, C., Nagy, N., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201344100 · Cited by 39
Amino acids and RagD potentiate mTORC1 activation in CD8 + T cells to confer antitumor immunity
Zhang, Y., Hu, H., Liu, W., Yan, S., Li, Y., Tan, L., Chen, Y., Liu, J., Peng, Z., Yuan, Y., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-002137 · Cited by 37
NFAT and NF-κB dynamically co-regulate TCR and CAR signaling responses in human T cells
Huang, W. L., Lin, W., Chen, B., Zhang, J., Gao, P., Fan, Y., Lin, Y., & Wei, P. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112663 · Cited by 40
Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy
Su, X., Li, J., Xu, X., Ye, Y., Wang, C., Pang, G., Liu, W., Liu, A., Zhao, C., & Hao, X. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05552-6 · Cited by 45
“Slow activation of co-stimulatory receptors and TCR signals may lead to inhibition of T cells activation and function [353].”
Background
High-affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells
Cochrane, R. W., Robino, R. A., Granger, B., Allen, E., Vaena, S. G., Romeo, M. J., de Cubas, A. A., Berto, S., & Ferreira, L. M. R. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101385 · Cited by 39
“74,75 Moreover, as mentioned previously, Tregs exhibit dampened activation of several pathways down-stream of TCR signaling.”
High intensity focused ultrasound enhances anti-tumor immunity by inhibiting the negative regulatory effect of miR-134 on CD86 in a murine melanoma model
Yuan, S., Li, H., Yang, M., Zha, H., Sun, H., Li, X.-R., Li, A., Gu, Y., Duan, L., Luo, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5285 · Cited by 38

Authors: Chen, L., & Flies, D. B.
Affiliations: Yale Cancer Center (US)
University of New Mexico (US)
Corresponding author: Chen, Lieping
ORCID: Chen, Lieping
Flies, Dallas B.
Venue: Nature Reviews Immunology
Publisher: Springer Science and Business Media LLC
Published: 2013-03-08
Volume: 13
Issue: 4
Pages: 227-242
ISSN: 1474-1733 (ISSN-L)
1474-1741
DOI: 10.1038/nri3405
PMC: PMC3786574
OpenAlex: W2130473166
Cited by: 3,114
References: 135
Citations by year: 2026: 148 · 2025: 258 · 2024: 259 · 2023: 276 · 2022: 305 · 2021: 312 · 2020: 310 · 2019: 250 · 2018: 275 · 2017: 238 · 2016: 195 · 2015: 148 · 2014: 101 · 2013: 35
FWCI: 13.52
Type: journal article
Language: en
Update notices: erratum (2013-06-05)
Open access: green
europepmc.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Immunology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Melanoma Research Alliance
National Cancer Institute (CA 97085, CA 16359, CA121974, CA86721, R01CA097085, CA142779, R01CA085721, R01CA142779, P50CA121974, P30CA016359)
National Institute of Allergy and Infectious Diseases (T32AI089704, R01AI072592, AI72592, T32AI007247)
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords: T cell costimulation, T cell co-inhibition, costimulatory receptors, co-inhibitory receptors, T cell receptor signaling, T cell activation, T cell differentiation, immune checkpoint molecules
MeSH terms: Humans, Lymphocyte Activation, Receptors, Antigen, T-Cell, T-Lymphocytes, Signal Transduction, CD28 Antigens, B7-1 Antigen, Models, Immunological, B7-2 Antigen, Receptors, Tumor Necrosis Factor, Member 14

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular mechanisms of T cell co-stimulation and co-inhibition

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks